Company: RPID
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001380106-25-000200
Chunk: 229

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 229
---
 Company's board of directors. In no event may an employee purchase more than 100,000 shares per offering period based on the closing price on the first trading date of an offering period or the last trading date of an offering period, or more than $25,000 worth of stock during any calendar year. The purchase price for shares to be purchased under the 2021 ESPP is 85% of the lesser of the market price of the Company's common stock on the first trading date of an offering period or on any purchase date during an offering period (March 14 or September 14).During the nine months ended September 30, 2025, there were 164,108 shares of Class A common stock purchased under the 2021 ESPP. The Company recognized less than $0.1 million of expense related to the 2021 ESPP for each of nine months ended September 30, 2025 and 2024. As of September 30, 2025, 1,170,124 shares were available for future issuance under the 2021 ESPP.

27

The Company estimates the fair value of shares issued to employees under the 2021 ESPP using the Black-Scholes option-pricing model. The following weighted average assumptions were used in the calculation of fair value of shares under the 2021 ESPP at the grant date for both the nine months ended September 30, 2025 and 2024:Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Risk-free interest rate3.8 %4.6 %4.2 %5.0 %Expected term (in years)0.50.50.50.5Expected volatility125.3 %42.6 %85.1 %46.0 %Expected dividend yield0 %0 %0 %0 %Stock-based compensationStock-based compensation expense was classified in the condensed consolidated statements of operations as follows (in thousands):Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Cost of revenue$114 $142 $327 $437 Research and development89 123 279 395 Sales and marketing102 98 302 325 General and administrative841 566 2,498 2,028 Total stock-based compensation expense$1,146 $929 $3,406 $3,185 As